Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof

The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.

Saved in:
Bibliographic Details
Main Authors Trotter, B. Wesley, Zhang, Hongjun, Barr, Kenneth Jay, Gunaydin, Hakan, Lapointe, Blair T, Liu, Kun
Format Patent
LanguageEnglish
Published 10.03.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
Bibliography:Application Number: US201615770257